This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Alimera Sciences Beheer
Beheer criteriumcontroles 1/4
We currently do not have sufficient information about the CEO.
Belangrijke informatie
Rick Eiswirth
Algemeen directeur
US$3.3m
Totale compensatie
| Percentage CEO-salaris | 18.5% |
| Dienstverband CEO | 5.7yrs |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | 2.1yrs |
| Gemiddelde ambtstermijn bestuur | 2.3yrs |
Recente managementupdates
Recent updates
Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$15m |
| Mar 31 2024 | n/a | n/a | -US$23m |
| Dec 31 2023 | US$3m | US$603k | -US$21m |
| Sep 30 2023 | n/a | n/a | -US$21m |
| Jun 30 2023 | n/a | n/a | -US$25m |
| Mar 31 2023 | n/a | n/a | -US$17m |
| Dec 31 2022 | US$974k | US$580k | -US$18m |
| Sep 30 2022 | n/a | n/a | -US$18m |
| Jun 30 2022 | n/a | n/a | -US$17m |
| Mar 31 2022 | n/a | n/a | -US$7m |
| Dec 31 2021 | US$890k | US$550k | -US$4m |
| Sep 30 2021 | n/a | n/a | -US$1m |
| Jun 30 2021 | n/a | n/a | US$2m |
| Mar 31 2021 | n/a | n/a | -US$8m |
| Dec 31 2020 | US$888k | US$550k | -US$5m |
| Sep 30 2020 | n/a | n/a | -US$4m |
| Jun 30 2020 | n/a | n/a | -US$6m |
| Mar 31 2020 | n/a | n/a | -US$9m |
| Dec 31 2019 | US$977k | US$525k | -US$10m |
| Sep 30 2019 | n/a | n/a | -US$12m |
| Jun 30 2019 | n/a | n/a | US$19m |
| Mar 31 2019 | n/a | n/a | US$22m |
| Dec 31 2018 | US$831k | US$495k | US$17m |
| Sep 30 2018 | n/a | n/a | US$11m |
| Jun 30 2018 | n/a | n/a | -US$22m |
| Mar 31 2018 | n/a | n/a | -US$23m |
| Dec 31 2017 | US$811k | US$425k | -US$22m |
Compensatie versus markt: Rick's total compensation ($USD3.26M) is above average for companies of similar size in the German market ($USD814.91K).
Compensatie versus inkomsten: Rick's compensation has increased whilst the company is unprofitable.
CEO
Rick Eiswirth (56 yo)
5.7yrs
Tenure
US$3,261,480
Compensatie
Mr. Richard S. Eiswirth, Jr., also known as Rick, served as Interim Chief Financial Officer at Alimera Sciences, Inc. since 2022. He has been President of Alimera Sciences, Inc. since January 1, 2016 until...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Director | 5.7yrs | US$3.26m | geen gegevens | |
| Chief Operating Officer | less than a year | US$1.39m | 0.41% € 1.1m | |
| President of International Operations | less than a year | US$1.02m | 0% € 0 | |
| Co-Founder | 21.3yrs | US$541.72k | 0% € 0 | |
| CFO & Treasurer | less than a year | geen gegevens | 0% € 0 | |
| VP, General Counsel & Secretary | 5.8yrs | geen gegevens | geen gegevens | |
| Chief Retina Specialist | 3.3yrs | geen gegevens | 0.0083% € 21.4k | |
| President of U.S. Operations | less than a year | geen gegevens | 0% € 0 |
2.1yrs
Gemiddelde duur
55.5yo
Gemiddelde leeftijd
Ervaren management: ASZ1's management team is considered experienced (2.1 years average tenure).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Director | 5.7yrs | US$3.26m | geen gegevens | |
| Independent Director | 14.4yrs | US$186.31k | 0% € 0 | |
| Director | less than a year | US$96.42k | 0% € 0 | |
| Director | 1.7yrs | US$124.63k | 0% € 0 | |
| Independent Director | 5.2yrs | US$172.21k | 0% € 0 | |
| Independent Director | 1.5yrs | US$151.70k | 0% € 0 | |
| Chairman of the Board | 1.5yrs | US$165.75k | 0% € 0 | |
| Director | 2.8yrs | US$172.52k | 0% € 0 |
2.3yrs
Gemiddelde duur
53.5yo
Gemiddelde leeftijd
Ervaren bestuur: ASZ1's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.